Table 4. Test outcomes when using non-rigorous sample inclusion criteria.
a) | Anti-ZIKV-IgM-positive (n = 22) | Anti-ZIKV-IgM-negative (n = 102) | b) | Anti-ZIKV-IgG-positive (n = 24) | Anti-ZIKV-IgG-negative (n = 84) |
---|---|---|---|---|---|
Acute-LFRET positive | 100% (n = 22) | 4% (n = 4) | Immunity-LFRET positive | 83% (n = 20) | 0% (n = 0) |
Acute-LFRET negative | 0% (n = 0) | 96% (n = 98) | Immunity-LFRET negative | 17% (n = 4) | 100% (n = 84) |
a) Acute-LFRET outcomes vs. IgM-reference tests
b) Immunity-LFRET outcomes vs. IgG-reference tests